Form 4 for AXSM Axsome Therapeutics, Inc.
Accepted 2025-06-23 00:00:00 ET · period of report 2025-06-20 · accession 0000950170-25-089158 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2025-06-23 | 2025-06-20+ | AXSM | Murdock Hunter R. | GC | S - Sale+OE | $101.42 | -13.5K | 0 | -100% | -$1.37M |
| DMT | 2025-06-23 | 2025-06-20+ | AXSM | Murdock Hunter R. | GC | M - OptEx | $29.91 | +13.5K | 7,500 | New | +$404.2K |
| DMT | 2025-06-23 | 2025-06-20+ | AXSM | Murdock Hunter R. | GC | M - OptEx | $0.00 | -13.5K | 16.4K | -45% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-23 | S | D | 6,014 | $100.12 | 0 | D | — | — | (F4) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $100.00 and $100.67. |
| 2 | Common | Common Stock | 2025-06-23 | M | A | 6,014 | $29.91 | 6,014 | D | — | — | |
| 3 | Common | Common Stock | 2025-06-20 | S | D | 7,500 | $102.47 | 0 | D | — | — | (F3) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $101.84 and $103.07 |
| 4 | Common | Common Stock | 2025-06-20 | M | A | 7,500 | $29.91 | 7,500 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy) | 2025-06-20 | M | D | 7,500 | $0.00 | 22,383 | D | $29.91 · 2023-03-04 to 2032-03-04 | 7,500 Common Stock | |
| 6 | Derivative | Stock Option (Right to Buy) | 2025-06-23 | M | D | 6,014 | $0.00 | 16,369 | D | $29.91 · 2023-03-04 to 2032-03-04 | 6,014 Common Stock |